¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"proximal common pathway"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • coagulation pathway
    ÀÀ°í°æ·Î
  • extrinsic pathway of coagulation
    ¿ÜÀμºÀÀ°í°æ·Î
  • intrinsic pathway of coagulation
    ³»ÀμºÀÀ°í°æ·Î
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
  • internodal pathway
    °áÀý°£°æ·Î
  • motor pathway
    ¿îµ¿½Å°æ·Î
  • metabolic pathway
    ´ë»ç°æ·Î
  • pain pathway
    ÅëÁõÀü´Þ·Î
  • pathway
    °æ·Î, Åë·Î
  • subthalamopallidal pathway
    ½Ã»ó¹ØÃ¢¹éÇÙ·Î
  • sensory pathway
    °¨°¢·Î
  • ubiquitin-protease pathway
    À¯ºñÄûƾ´Ü¹éºÐÇØÈ¿¼ÒÅë·Î
  • visual pathway
    ½Ã°¢°æ·Î
  • common
    1. °øÅë- 2. ¿Â-, ÃÑ- 3. °øµ¿-
  • common antigen
    °øÅëÇ׿ø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • metabolic pathway
    ´ë»ç°æ·Î
  • motor pathway
    ¿îµ¿½Å°æ·Î
  • pathway
    °æ·Î, Åë·Î
  • pain pathway
    ÅëÁõÀü´Þ·Î
  • sensory pathway
    °¨°¢·Î
  • subthalamopallidal pathway
    ½Ã»ó¹ØÃ¢¹éÇÙ·Î, ½Ã»óÇÏ´ãⱸ·Î
  • transcellular pathway
    ¼¼Æ÷Ⱦ´Ü°æ·Î
  • visual pathway
    ½Ã°¢°æ·Î
  • common antigen
    °øÅëÇ׿ø
  • common carotid artery
    ¿Â¸ñµ¿¸Æ
  • common hepatic artery
    ¿Â°£µ¿¸Æ
  • common iliac artery
    ¿Â¾ûµ¢µ¿¸Æ
  • common interosseous artery
    ¿Â»À»çÀ̵¿¸Æ
  • common palmar digital artery
    ¿Â¹Ù´ÚÂʼհ¡¶ôµ¿¸Æ
  • common plantar digital artery
    ¿Â¹Ù´ÚÂʹ߰¡¶ôµ¿¸Æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • proximal centriole
    ¸Ó¸®ÂÊÁ߽ɼÒü
  • proximal cephalic vein
    ±ÙÀ§ µÎ(ºÎ)Á¤¸Æ
  • proximal contact
    ÀÎÁ¢(ìäïÈ).
  • proximal convergence
    ±ÙÁ¢(½Ã)´«¸ðÀ½, ±ÙÁ¢(½Ã)ÆøÁÖ
  • proximal convoluted tubule
    Å丮Âʰö½½¼¼°ü
  • proximal cornua
    ±ÙÀ§»Ô, ±ÙÀ§°¢(ÐÎêÈÊÇ).
  • proximal end
    ±ÙÀ§´Ü
  • proximal facial nerve
    ±ÙÀ§¾È¸é½Å°æ
  • proximal interphalangeal joint
    ±ÙÀ§Áö°£ °üÀý(ÐÎêÈò¦Êàμï½).
  • proximal lingual tubercle
    ¸öÂÊÇô°áÀý
  • proximal muscle
    ±ÙÀ§±Ù(ÐÎêÈÐÉ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • proximal interphalangeal joint
    ±ÙÀ§Áö°£ °üÀý(ÐÎêÈò¦Êàμï½).
  • proximal lingual tubercle
    ¸öÂÊÇô°áÀý
  • proximal muscle
    ±ÙÀ§±Ù(ÐÎêÈÐÉ).
  • proximal part
    ¸öÂʺκÐ
  • proximal phalanges
    ù¸¶µð»À
  • proximal phalanx
    ±ÙÀ§Áö°ñ.
  • proximal phalanx
    ±ÙÀ§Áö °ñ.
  • proximal radio-ulnar joint
    ¸öÂʳëÀÚ°üÀý
  • proximal renal tubular acidosis
    ±ÙÀ§¿ä¼¼°ü»ê¼ºÁõ(ÐÎêÈèñá¬Î·ß«àõñø).
  • proximal renal tubular acidosis
    ±ÙÀ§¿ä¼¼°ü»ê¼ºÁõ(ÐÎêÈèñá¬Î·ß«àõñø)
  • proximal sphincter
    ±ÙÀ§°ý¾à±Ù
  • proximal straight tubule
    Å丮ÂʰðÀº¼¼°ü
  • proximal surface
    ±âÀú¸é(Ðñî¼Øü).
  • proximal tubule
    ±ÙÀ§¿ä¼¼°ü(ÐÎêÈèñá¬Î·).
  • proximal vitelline part
    ¸öÂʳ­È²ºÎºÐ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Common dorsal mesentery
    ¿ÂµîÂÊâÀÚ°£¸·
    [¿¾ ¿ë¾î] ÃѹèÃøÀå°£¸·
  • Common carotid artery
    ¿Â¸ñµ¿¸Æ
    [¿¾ ¿ë¾î] ÃѰ浿¸Æ(°£)
  • Common carotid artery (partial)
    ¿Â¸ñµ¿¸Æ(ºÎºÐ)
    [¿¾ ¿ë¾î] ÃѰ浿¸Æ
  • Common carotid plexus
    ¿Â¸ñ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ÃѰ浿¸Æ½Å°æÃÑ
  • Common basal vein
    ¿Â¹Ù´ÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÃÑÆóÀúÁ¤¸Æ
  • Common plantar digital arteries
    ¿Â¹Ù´ÚÂʹ߰¡¶ôµ¿¸Æ
    [¿¾ ¿ë¾î] ÃÑ̫̿Áöµ¿¸Æ
  • Common plantar digital nerves
    ¿Â¹Ù´ÚÂʹ߰¡¶ô½Å°æ
    [¿¾ ¿ë¾î] ÃÑ̫̿Áö½Å°æ
  • Common palmar digital arteries
    ¿Â¹Ù´ÚÂʼհ¡¶ôµ¿¸Æ
    [¿¾ ¿ë¾î] ÃÑÀåÃøÁöµ¿¸Æ
  • Common palmar digital nerves
    ¿Â¹Ù´ÚÂʼհ¡¶ô½Å°æ
    [¿¾ ¿ë¾î] ÃÑÀåÃøÁö½Å°æ
  • Common membranous crus
    ¿Â¹Ý°í¸®°ü´Ù¸®
    [¿¾ ¿ë¾î] ÃѰ¢
  • Common interosseous artery
    ¿Â»À»çÀ̵¿¸Æ
    [¿¾ ¿ë¾î] ÃѰñ°£µ¿¸Æ
  • Common iliac artery
    ¿Â¾ûµ¢µ¿¸Æ
    [¿¾ ¿ë¾î] ÃÑÀå°ñµ¿¸Æ
  • Common iliac lymph nodes
    ¿Â¾ûµ¢¸²ÇÁÀý
    [¿¾ ¿ë¾î] ÃÑÀå°ñÀÓÆÄÀý
  • Common iliac vein
    ¿Â¾ûµ¢Á¤¸Æ
    [¿¾ ¿ë¾î] ÃÑÀå°ñµ¿¸Æ
  • Common iliac vein
    ¿Â¾ûµ¢Á¤¸Æ
    [¿¾ ¿ë¾î] ÃÑÀå°ñÁ¤¸Æ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ED pathway
    ED °æ·Î(ÌèÖØ)
  • Embden-Meyerhof pathway
    ¿¥µ§-¸¶À̾îÈ£ÇÁ °æ·Î(ÌèÖØ)
  • Entner-Doudoroff pathway
    ¿£Æ®³Ê-µÎµµ·ÎÇÁ °æ·Î(ÌèÖØ)
  • extrinsic pathway
    ¿ÜÀÎ °æ·Î (èâì×ÌèÖØ)
  • feeder pathway
    °ø±Þ °æ·Î (ÍêÐåÌèÖØ)
  • fumarate pathway
    Ç»¸¶¸£»ê(ß«) °æ·Î(ÌèÖØ)
  • glucuronate pathway
    ±Û·çÅ¥·Ð»ê(ß«) °æ·Î(ÌèÖØ)
  • glucuronic acid oxidation pathway
    ±Û·çÅ¥·Ð»ê(ß«) »êÈ­°æ·Î(ß«ûùÌèÖØ)
  • glycerate pathway
    ±Û¸®¼¼¸£»ê(ß«) °æ·Î(ÌèÖØ)
  • glycolytic pathway
    ´çºÐÇØ °æ·Î(ÓØÝÂú°ÌèÖØ)
  • hexose diphosphate pathway
    ÀÌÀλê(ì£×òß«) Çí¼Ò½º °æ·Î (ÌèÖØ)
  • hexose monophosphate oxidative pathway
    ÀÏÀλê(ìé×òß«) Çí¼Ò½º »êÈ­°æ·Î (ß«ûùÌèÖØ)
  • hexose monophosphate pathway
    ÀÏÀλê(ìé×òß«) Çí¼Ò½º °æ·Î(ÌèÖØ)
  • hoxose phosphoketolase pathway
    Çí¼Ò½º Æ÷½ºÆ÷ŰÅç·¹À̽º °æ·Î(ÌèÖØ)
  • intrinsic pathway
    ³»ÀÎ °æ·Î(Ò®ì×ÌèÖØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CMR cardiomodulorespirography; cerebral metabolic rate; chief medical resident; common medical record; c...
HCPCS Health Care Financing Administration common procedural collecting system; Health Care Financing Admi...
ACP accessory conduction pathway; acid phosphatase; acyl carrier protein; American College of Pathologis...
AERPAP antegrade effective refractory period accessory pathway
APH alcohol-positive history; alternative pathway hemolysis; aminoglycoside phosphotransferase; antepart...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HMP Hexose monophosphate pathway
rTFPI Recombinant tissue factor pathway inhibitor
TFPI TF pathway inhibitor
TFPI Tissue Factor Pathway Inhibitor
TFPI-2 Tissue factor pathway inhibitor-2
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • common atrioventricular canal
    °øÅë ¹æ½Ç°ü
  • common bile duct
    ÃÑ ´ã°ü
  • common carotid artery
    ÃÑ ¸ñµ¿¸Æ, ÃÑ °æµ¿¸Æ
    µÎ°æºÎ¿¡ ºÐÆ÷ÇÏ´Â µ¿¸ÆÀÇ ÁÖµÈ °¡Áö·Î ¿ì´Â ¿ÏµÎµ¿¸Æ¿¡¼­ Á´ ´ëµ¿¸Æ±Ã¿¡¼­ °¢°¢ ºÐ±âÇÏ¿© ±â°ü°ú ÈĵÎÀÇ ¿ÜÃøÀ» Áö³ª¼­ »óÇàÇÏ¿© °©»ó ¿¬°ñ »ó¿¬ÀÇ ³ôÀÌ¿¡¼­ ³»°æµ¿¸Æ°ú ³»°æµ¿¸ÆÀ¸·Î ³ª´µ¾îÁø´Ù.
  • common carotid plexus
    ¿Â¸ñ µ¿¸Æ ½Å°æ ¾ó±â, ÃÑ °æµ¿¸Æ ½Å°æÃÑ
  • common drug
    º¸Åë ¾à
  • common facial vein
    ¿Â ¾ó±¼ Á¤¸Æ, ÃѾȸé Á¤¸Æ
  • common feature
    ÀϹÝÀûÀÎ ¼Ò°ß
  • common iliac artery
    ÃÑÀå°ñ µ¿¸Æ
  • common interosseous artery
    ÃÑ»À »çÀÌ µ¿¸Æ, ÃѰñ°£ µ¿¸Æ
  • common migraine
    ÀÏ¹Ý ÆíµÎÅë, ÀϹÝÀûÀÎ ÆíµÎÅë, ÀϹÝÀû ÆíµÎÅë, ÀϹÝÇü ÆíµÎÅë
    migraine without aura¸¦ º¸½Ã¿À.
  • common mole
    ½É»ó ¸ð¹Ý
  • common nasal meatus
    ÃÑ ºñµµ
  • common palmar digital artery
    ¿Â ¹Ù´ÚÂÊ ¼Õ°¡¶ô µ¿¸Æ
  • common pharyngeal duct
    ÃÑ ÀεΠ°ü
  • common sense
    °øÅë °¨°¢
    ¸ðµç °¨°ü¿¡ °øÅëµÇ´Â °¨°¢. ÀÏ¹Ý °¨°¢À̶ó°íµµ ÇÑ´Ù. ƯÁ¤ÇÑ °¨°ü¿¡¸¸ ´ëÀÀÇÏ´Â °íÀ¯ÀÇ °¨°¢°ú´Â ±¸º°µÈ´Ù. ¾Æ¸®½ºÅä·¼·¹½ºÀÇ ¡¶Á¤½Å·Ð£ºDe Anima¡·¿¡¼­´Â ¿îµ¿, Á¤Áö, ¼ö, ¸ð¾ç, Å©±âÀÇ Áö°¢À» °øÅë °¨°¢À̶ó Çϰí, ºû±ò¡ª½Ã°¢, ¼Ò¸®¡ªÃ»°¢°ú °°Àº ƯÁ¤ °¨°¢°ú ±¸º°ÇÏ¿´´Ù. T. ¸®µå, A. ÆÛ°Å½¼ µîÀ» Áß½ÉÀ¸·Î ÇÏ´Â ¿µ±¹ÀÇ ¡®»ó½Ä öÇÐ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
alternative oxidase pathway Pathway of mitochondrial electron transport in higher plants, particularly in fruits and seeds, that does not involve cytochrome oxidase and thus is resistant to cyanide.
(18 Nov 1997)
alternative pathway See: complement activation.
(18 Nov 1997)
anabolic pathway <biochemistry> A reaction or series of reactions in a metabolic pathway that synthesise complex molecules from simpler ones, usually requiring the input of energy.
Compare: catabolic pathway.
(09 Oct 1997)
auditory pathway Neural paths and connections within the central nervous system, beginning at the organ of Corti's hair cells, continuing along the eighth nerve, and terminating at the auditory cortex.
(05 Mar 2000)
GABA pathway The pathway that ultimately converts 4-aminobutyrate to succinate; succinate is then converted to alpha-ketoglutarate, via the tricarboxylic acid cycle, which is then acted upon by glutamate dehydrogenase; glutamate is then decarboxylated to reform 4-aminobutyrate; an important pathway for those cells which make this neuroactive molecule.
Synonym: GABA pathway.
(05 Mar 2000)
Palade pathway <cell biology> The routing of proteins from the site of their synthesis to the final cellular or secreted position. Several different pathways are known and others suspected. Glycosylation of the proteins may provide specific address labels for the proteins.
(18 Nov 1997)
catabolic pathway <biochemistry> A series of reactions in a metabolic pathway that break down complex compounds into simpler ones, usually releasing energy in the process.
Compare: anabolic pathway.
(16 Mar 1998)
pathway 1. A collection of axons establishing a conduction route for nerve impulses from one group of nerve cells to another group or to an effector organ composed of muscle or gland cells.
2. Any sequence of chemical reactions leading from one compound to another; if taking place in living tissue, usually referred to as a biochemical pathway.
(05 Mar 2000)
visual pathway Neural paths and connections within the central nervous system, beginning with the retina and terminating in the occipital cortex.
(05 Mar 2000)
pentose phosphate pathway <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate.
Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses.
In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection.
Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose.
(18 Nov 1997)
perforant pathway A pathway of fibres originating in the lateral part of the entorhinal area, perforating the subiculum of the hippocampus, and running into the stratum moleculare of the hippocampus, where these fibres synapse with others that go to the dentate gyrus. It is also called the perforating fasciculus.
(12 Dec 1998)
mercapturic acid pathway A glutathione-dependent pathway for the detoxification of a number of compounds, including arene oxides; an S-substituted glutathione is formed and ultimately converted to a mercapturic acid (an S-substituted N-acetylated l-cysteine), which is excreted; the leukotrienes are believed to be degraded through this pathway.
(05 Mar 2000)
RMP pathway <biochemistry> Ribulose monophosphate pathway, also called allulose phosphate pathway. A metabolic pathway used by methylotropic bacteria for the conversion of formaldehyde to hexose sugars etc. In the first stage ribulose 5 phosphate is condensed with HCHO.
(23 Aug 1998)
phosphogluconate pathway <biochemistry> This oxidative pathway starts with glucose-6-phosphate andeventually results in the creation of pentose phosphates and NADPH.
(09 Oct 1997)
complement pathway, alternative The complement activation sequence initiated by the activation of complement factor c3, which is triggered by the interaction of microbial polysaccharides and properdin without participation of an antigen-antibody reaction.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • common factor
    =COMMON DIVISOR
  • common fraction
    »óºÐ¼ö
  • common gas
    ·¹±Ö·¯(¹«¿¬) ÈÖ¹ßÀ¯
  • common gender
    Å뼺(³²³à ¾ç¼º¿¡ ÅëÇÏ´Â `parent'µî)
  • common good
    °øÀÍ
  • common ground
    (»çȸ °ü°è.³íÀï.»óÈ£ ÀÌÇØ µîÀÇ)°øÅë±â¹Ý;µ¿°¨ÀÌ¿ä!
  • common informer
    Á÷¾÷Àû ¹Ð°íÀÚ
  • common jury
    (ÀϹÝÀÎÀ¸·Î µÈ)º¸Åë ¹è½É
  • common land
    °øÀ¯Áö;°ø¿ëÁö
  • common law
    °ü½À¹ý;ºÒ¹®À²
  • common lodging (house)
    °£ÀÌ ¼÷¹Ú¼Ò
  • common logarithm
    »ó¿ë ´ë¼ö
  • common market
    °øµ¿½ÃÀå
  • common marketeer
    EEC°¡ÀÔ Âù¼ºÀÚ
  • common measure
    °ø¾à¼ö;=COMMON TIME;º¸Åë·ü µî)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á